Literature DB >> 31160012

ONCOhabitats: A system for glioblastoma heterogeneity assessment through MRI.

Javier Juan-Albarracín1, Elies Fuster-Garcia2, Germán A García-Ferrando2, Juan M García-Gómez2.   

Abstract

BACKGROUND: Neuroimaging analysis is currently crucial for an early assessment of glioblastoma, to help improving treatment and tumor follow-up. To this end, multiple functional and morphological MRI sequences are usually employed, requiring the development of automated tools capable to extract the relevant information from these sources. In this work we present ONCOhabitats (https://www.oncohabitats.upv.es): an online open access system for glioblastoma analysis based on MRI data.
METHODS: ONCOhabitats provides two main services for untreated glioblastomas: (1) malignant tissue segmentation, and (2) vascular heterogeneity assessment of the tumor. The segmentation service implements a deep patch-wise 3D Convolutional Neural Network with residual connections. The vascular heterogeneity assessment service implements the Hemodynamic Tissue Signature (HTS) method patented in P201431289, which aims to identify habitats within the tumor with early prognostic capabilities.
RESULTS: The segmentation service was validated against the BRATS 2017 reference dataset, showing comparable results with current state-of-the-art methods (whole tumor Dice segmentation: 0.89). The vascular heterogeneity assessment service was validated in a retrospective cohort of 50 patients, in a study focused on predicting patient overall survival based on the HTS habitats. Cox proportional hazard regression analysis and Kaplan-Meier survival study showed significant positive correlations (p-value <.05) between the HTS habitats and patient overall survival. ONCOhabitats system also generates radiological reports for each service, including volumetries and perfusion measurements of the different regions of the lesion.
CONCLUSION: ONCOhabitats system provides open-access services for glioblastoma heterogeneity assessment, implementing consolidated state-of-the-art techniques for medical image analysis. Additionally, we also give access to the scientific community to our computational resources, offering a computational capacity of about 300 cases per day.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Deep learning; Glioblastoma segmentation; Heterogeneity assessment; Online system; Perfusion quantification; Unsupervised learning

Mesh:

Year:  2019        PMID: 31160012     DOI: 10.1016/j.ijmedinf.2019.05.002

Source DB:  PubMed          Journal:  Int J Med Inform        ISSN: 1386-5056            Impact factor:   4.046


  8 in total

Review 1.  High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion and Diffusion Techniques.

Authors:  Otto M Henriksen; María Del Mar Álvarez-Torres; Patricia Figueiredo; Gilbert Hangel; Vera C Keil; Ruben E Nechifor; Frank Riemer; Kathleen M Schmainda; Esther A H Warnert; Evita C Wiegers; Thomas C Booth
Journal:  Front Oncol       Date:  2022-03-03       Impact factor: 5.738

2.  Local detection of microvessels in IDH-wildtype glioblastoma using relative cerebral blood volume: an imaging marker useful for astrocytoma grade 4 classification.

Authors:  María Del Mar Álvarez-Torres; Elies Fuster-García; Javier Juan-Albarracín; Gaspar Reynés; Fernando Aparici-Robles; Jaime Ferrer-Lozano; Juan Miguel García-Gómez
Journal:  BMC Cancer       Date:  2022-01-06       Impact factor: 4.430

3.  Quantification of Tissue Compression Identifies High-Grade Glioma Patients with Reduced Survival.

Authors:  Elies Fuster-Garcia; Ivar Thokle Hovden; Siri Fløgstad Svensson; Christopher Larsson; Jonas Vardal; Atle Bjørnerud; Kyrre E Emblem
Journal:  Cancers (Basel)       Date:  2022-03-28       Impact factor: 6.639

4.  Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study.

Authors:  Michele Bailo; Nicolò Pecco; Marcella Callea; Paola Scifo; Filippo Gagliardi; Luca Presotto; Valentino Bettinardi; Federico Fallanca; Paola Mapelli; Luigi Gianolli; Claudio Doglioni; Nicoletta Anzalone; Maria Picchio; Pietro Mortini; Andrea Falini; Antonella Castellano
Journal:  Front Neurosci       Date:  2022-07-13       Impact factor: 5.152

5.  Ellipsoid calculations versus manual tumor delineations for glioblastoma tumor volume evaluation.

Authors:  Clara Le Fèvre; Roger Sun; Hélène Cebula; Alicia Thiery; Delphine Antoni; Roland Schott; François Proust; Jean-Marc Constans; Georges Noël
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

Review 6.  Identifying clinically applicable machine learning algorithms for glioma segmentation: recent advances and discoveries.

Authors:  Niklas Tillmanns; Avery E Lum; Gabriel Cassinelli; Sara Merkaj; Tej Verma; Tal Zeevi; Lawrence Staib; Harry Subramanian; Ryan C Bahar; Waverly Brim; Jan Lost; Leon Jekel; Alexandria Brackett; Sam Payabvash; Ichiro Ikuta; MingDe Lin; Khaled Bousabarah; Michele H Johnson; Jin Cui; Ajay Malhotra; Antonio Omuro; Bernd Turowski; Mariam S Aboian
Journal:  Neurooncol Adv       Date:  2022-06-14

7.  MGMT methylation may benefit overall survival in patients with moderately vascularized glioblastomas.

Authors:  Elies Fuster-Garcia; David Lorente Estellés; María Del Mar Álvarez-Torres; Javier Juan-Albarracín; Eduard Chelebian; Alex Rovira; Cristina Auger Acosta; Jose Pineda; Laura Oleaga; Enrique Mollá-Olmos; Silvano Filice; Paulina Due-Tønnessen; Torstein R Meling; Kyrre E Emblem; Juan M García-Gómez
Journal:  Eur Radiol       Date:  2020-10-01       Impact factor: 5.315

8.  DCE-MRI in Glioma, Infiltration Zone and Healthy Brain to Assess Angiogenesis: A Biopsy Study.

Authors:  Vera C Keil; Gerrit H Gielen; Bogdan Pintea; Peter Baumgarten; Angeliki Datsi; Kanishka Hittatiya; Matthias Simon; Elke Hattingen
Journal:  Clin Neuroradiol       Date:  2021-04-26       Impact factor: 3.649

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.